Analyst Ratings for Enliven Therapeutics (ELVN)
ELVN Rating Summary
ELVN Price Target Summary
- Highest: $52.00 (Baird)
- Lowest: $37.00 (Goldman Sachs)
- Average: $45.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.50 (+54.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$45.50 (+54.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/16/2025 | Goldman Sachs | Salveen Richter | New Coverage | Buy (N/A) |
37.00 (N/A) |
21.91 (29.44) |
34.37% | Details |
| 12/13/2024 | BTIG » Updated 8/14/2025 |
Justin Zelin | New Coverage | Buy (N/A) |
45.00 (N/A) |
23.00 (29.44) |
28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
